Literature DB >> 14986784

Homeopathic remedies as placebo alternatives--verification on the example of treatment of menopause-related vegetative and emotional disturbances.

Bohdan W Wasilewski1.   

Abstract

With the example of treatment of menopause-related vegetative and emotional disturbances, the author verifies the effectiveness of the use of Ignatia amara containing complex homeopathic remedies (IACCHR) as an alternative to placebo. Substantial improvement in psychological and psychosomatic symptoms was observed. Climacteric complaints diminished or disappeared completely in the majority of women (95.7% by patient evaluation and 96.2% by physician evaluation). Compared to standard pharmaceuticals, IACCHR treatment was tolerated better and lower risk of side effects was observed. The results obtained in this work indicate the significant therapeutic potential of this group of treatments, which is in line with the therapeutic effect of the placebo. Nevertheless, the showing of specific effects in pharmacological tests disqualifies the investigated treatments from use in a clinical trial in place of a placebo.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14986784     DOI: 10.1007/s11948-004-0075-8

Source DB:  PubMed          Journal:  Sci Eng Ethics        ISSN: 1353-3452            Impact factor:   3.525


  9 in total

Review 1.  The biochemical bases of the placebo effect.

Authors:  Raúl de la Fuente-Fernández; A Jon Stoessl
Journal:  Sci Eng Ethics       Date:  2004-01       Impact factor: 3.525

2.  Onset of action under antidepressant treatment.

Authors:  H H Stassen; J Angst; A Delini-Stula
Journal:  Eur Psychiatry       Date:  1997       Impact factor: 5.361

3.  Are the clinical effects of homeopathy placebo effects? A meta-analysis of placebo-controlled trials.

Authors:  K Linde; N Clausius; G Ramirez; D Melchart; F Eitel; L V Hedges; W B Jonas
Journal:  Lancet       Date:  1997-09-20       Impact factor: 79.321

4.  Efficacy and safety of tianeptine in the treatment of depressive disorders in comparison with fluoxetine*

Authors:  H. Lôo; J. Saiz-Ruiz; J. A. Costa E Silva; M. Ansseau; R. Herrington; A. Vaz-Serra; H. Dilling; S. De Risio
Journal:  Hum Psychopharmacol       Date:  2001-01       Impact factor: 1.672

Review 5.  Nonspecific medication side effects and the nocebo phenomenon.

Authors:  Arthur J Barsky; Ralph Saintfort; Malcolm P Rogers; Jonathan F Borus
Journal:  JAMA       Date:  2002-02-06       Impact factor: 56.272

Review 6.  Placebos, drug effects, and study design: a clinician's guide.

Authors:  F M Quitkin
Journal:  Am J Psychiatry       Date:  1999-06       Impact factor: 18.112

7.  Characteristics of placebo responses in medical treatment of premenstrual syndrome.

Authors:  E W Freeman; K Rickels
Journal:  Am J Psychiatry       Date:  1999-09       Impact factor: 18.112

Review 8.  Placebo response in studies of major depression: variable, substantial, and growing.

Authors:  B Timothy Walsh; Stuart N Seidman; Robyn Sysko; Madelyn Gould
Journal:  JAMA       Date:  2002-04-10       Impact factor: 56.272

9.  Delayed onset of action of antidepressant drugs? Survey of recent results.

Authors:  H H Stassen; J Angst; A Delini-Stula
Journal:  Eur Psychiatry       Date:  1997       Impact factor: 5.361

  9 in total
  1 in total

Review 1.  Placebo: its action and place in health research today--summary and conclusions.

Authors:  Raymond E Spier
Journal:  Sci Eng Ethics       Date:  2004-01       Impact factor: 3.525

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.